NGENLA Trademark

Trademark Overview


On Wednesday, August 15, 2018, a trademark application was filed for NGENLA with the United States Patent and Trademark Office. The USPTO has given the NGENLA trademark a serial number of 88079283. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2019. This trademark is owned by Pfizer Inc.. The NGENLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use; human growth hormones
ngenla

General Information


Serial Number88079283
Word MarkNGENLA
Filing DateWednesday, August 15, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use; human growth hormones

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, September 3, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 2, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 23, 2018ASSIGNED TO EXAMINER
Thursday, August 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 18, 2018NEW APPLICATION ENTERED IN TRAM